BioSpace News Archive

The Blue Cross Blue Shield Association announced that the Blue Distinction Total Care® (Total Care) program is outperforming other care providers in key health care quality and patient health metrics since its launch just a few years ago.

Khondrion announced the publication of a scientific article reporting on the development and unique mode of action of KH176, a clinical-stage drug candidate for the treatment of mitochondrial diseases.

WIRED Brand Lab and Pfizer’s GET OLD program have teamed up to create The Future of Getting Old, a trend report identifying six areas associated with aging, and the science and technology that may be changing what ‘getting old’ looks like.

Mr. Hamermesh will lead the business operations and corporate development strategies for the company

Studies demonstrate the efficacy of the STERIZONE® VP4 Sterilizer for inactivation of prions.

Reports First-Quarter Diluted EPS of $1.74 on a GAAP Basis; Adjusted Diluted EPS of $1.87 Reflects Growth of 46.1 Percent

The American Migraine Foundation and ZS have partnered to create one of the most comprehensive registries to study migraine and other headache disorders

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, will present a trial-in-progress poster presentation from its global, multi-center, registration-directed open-label Phase 2b clinical trial, PISCES/KEYNOTE-695, assessing the OncoSec’s investigational therapy.

Genomic Health, Inc. has been informed of the acceptance of the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, for presentation by the ECOG-ACRIN Cancer Research Group.

Funds to be Used for Clinical Studies and Commercial Expansion in the European Union and Australia